Medical Care
Global Peripheral Parenteral Nutrition (PPN) Market Research Report 2025
- Apr 07, 25
- ID: 167818
- Pages: 89
- Figures: 87
- Views: 31
The global market for Peripheral Parenteral Nutrition (PPN) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Peripheral Parenteral Nutrition (PPN) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Peripheral Parenteral Nutrition (PPN) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Peripheral Parenteral Nutrition (PPN) in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Peripheral Parenteral Nutrition (PPN) include Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, Laboratorios Biogalenic, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peripheral Parenteral Nutrition (PPN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Parenteral Nutrition (PPN).
The Peripheral Parenteral Nutrition (PPN) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peripheral Parenteral Nutrition (PPN) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Parenteral Nutrition (PPN) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eurofarma
Corporacion De Laboratorios Farmaceuticos
Baxter International Inc.
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
Laboratorios Biogalenic
Laboratorios Finlay
Grifols International
Fresenius Kabi
Sichuan Kelun Pharmaceutical
Segment by Type
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins and Minerals
Segment by Application
Hospital
Home
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peripheral Parenteral Nutrition (PPN) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Peripheral Parenteral Nutrition (PPN) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Peripheral Parenteral Nutrition (PPN) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Peripheral Parenteral Nutrition (PPN) in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Peripheral Parenteral Nutrition (PPN) include Eurofarma, Corporacion De Laboratorios Farmaceuticos, Baxter International Inc., Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, Laboratorios Biogalenic, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peripheral Parenteral Nutrition (PPN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Parenteral Nutrition (PPN).
The Peripheral Parenteral Nutrition (PPN) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peripheral Parenteral Nutrition (PPN) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Parenteral Nutrition (PPN) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eurofarma
Corporacion De Laboratorios Farmaceuticos
Baxter International Inc.
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
Laboratorios Biogalenic
Laboratorios Finlay
Grifols International
Fresenius Kabi
Sichuan Kelun Pharmaceutical
Segment by Type
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Trace Elements
Vitamins and Minerals
Segment by Application
Hospital
Home
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peripheral Parenteral Nutrition (PPN) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Carbohydrates
1.2.3 Parenteral Lipid Emulsion
1.2.4 Single Dose Amino Acid Solution
1.2.5 Trace Elements
1.2.6 Vitamins and Minerals
1.3 Market by Application
1.3.1 Global Peripheral Parenteral Nutrition (PPN) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Home
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Parenteral Nutrition (PPN) Market Perspective (2020-2031)
2.2 Global Peripheral Parenteral Nutrition (PPN) Growth Trends by Region
2.2.1 Global Peripheral Parenteral Nutrition (PPN) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peripheral Parenteral Nutrition (PPN) Historic Market Size by Region (2020-2025)
2.2.3 Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Region (2026-2031)
2.3 Peripheral Parenteral Nutrition (PPN) Market Dynamics
2.3.1 Peripheral Parenteral Nutrition (PPN) Industry Trends
2.3.2 Peripheral Parenteral Nutrition (PPN) Market Drivers
2.3.3 Peripheral Parenteral Nutrition (PPN) Market Challenges
2.3.4 Peripheral Parenteral Nutrition (PPN) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Parenteral Nutrition (PPN) Players by Revenue
3.1.1 Global Top Peripheral Parenteral Nutrition (PPN) Players by Revenue (2020-2025)
3.1.2 Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Players (2020-2025)
3.2 Global Peripheral Parenteral Nutrition (PPN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peripheral Parenteral Nutrition (PPN) Revenue
3.4 Global Peripheral Parenteral Nutrition (PPN) Market Concentration Ratio
3.4.1 Global Peripheral Parenteral Nutrition (PPN) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Parenteral Nutrition (PPN) Revenue in 2024
3.5 Global Key Players of Peripheral Parenteral Nutrition (PPN) Head office and Area Served
3.6 Global Key Players of Peripheral Parenteral Nutrition (PPN), Product and Application
3.7 Global Key Players of Peripheral Parenteral Nutrition (PPN), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Parenteral Nutrition (PPN) Breakdown Data by Type
4.1 Global Peripheral Parenteral Nutrition (PPN) Historic Market Size by Type (2020-2025)
4.2 Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Type (2026-2031)
5 Peripheral Parenteral Nutrition (PPN) Breakdown Data by Application
5.1 Global Peripheral Parenteral Nutrition (PPN) Historic Market Size by Application (2020-2025)
5.2 Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peripheral Parenteral Nutrition (PPN) Market Size (2020-2031)
6.2 North America Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025)
6.4 North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peripheral Parenteral Nutrition (PPN) Market Size (2020-2031)
7.2 Europe Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025)
7.4 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size (2020-2031)
8.2 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2020-2025)
8.4 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peripheral Parenteral Nutrition (PPN) Market Size (2020-2031)
9.2 Latin America Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025)
9.4 Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size (2020-2031)
10.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025)
10.4 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofarma
11.1.1 Eurofarma Company Details
11.1.2 Eurofarma Business Overview
11.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) Introduction
11.1.4 Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.1.5 Eurofarma Recent Development
11.2 Corporacion De Laboratorios Farmaceuticos
11.2.1 Corporacion De Laboratorios Farmaceuticos Company Details
11.2.2 Corporacion De Laboratorios Farmaceuticos Business Overview
11.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Introduction
11.2.4 Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.2.5 Corporacion De Laboratorios Farmaceuticos Recent Development
11.3 Baxter International Inc.
11.3.1 Baxter International Inc. Company Details
11.3.2 Baxter International Inc. Business Overview
11.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Introduction
11.3.4 Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.3.5 Baxter International Inc. Recent Development
11.4 Kelun Pharma
11.4.1 Kelun Pharma Company Details
11.4.2 Kelun Pharma Business Overview
11.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Introduction
11.4.4 Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.4.5 Kelun Pharma Recent Development
11.5 B. Braun
11.5.1 B. Braun Company Details
11.5.2 B. Braun Business Overview
11.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) Introduction
11.5.4 B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.5.5 B. Braun Recent Development
11.6 Fresenius
11.6.1 Fresenius Company Details
11.6.2 Fresenius Business Overview
11.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) Introduction
11.6.4 Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.6.5 Fresenius Recent Development
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Details
11.7.2 Teva Pharmaceutical Industries Business Overview
11.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Introduction
11.7.4 Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.7.5 Teva Pharmaceutical Industries Recent Development
11.8 Pfizer (Hospira)
11.8.1 Pfizer (Hospira) Company Details
11.8.2 Pfizer (Hospira) Business Overview
11.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Introduction
11.8.4 Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.8.5 Pfizer (Hospira) Recent Development
11.9 Ostuka Pharmaceutical
11.9.1 Ostuka Pharmaceutical Company Details
11.9.2 Ostuka Pharmaceutical Business Overview
11.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Introduction
11.9.4 Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.9.5 Ostuka Pharmaceutical Recent Development
11.10 Laboratorios Biogalenic
11.10.1 Laboratorios Biogalenic Company Details
11.10.2 Laboratorios Biogalenic Business Overview
11.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Introduction
11.10.4 Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.10.5 Laboratorios Biogalenic Recent Development
11.11 Laboratorios Finlay
11.11.1 Laboratorios Finlay Company Details
11.11.2 Laboratorios Finlay Business Overview
11.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Introduction
11.11.4 Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.11.5 Laboratorios Finlay Recent Development
11.12 Grifols International
11.12.1 Grifols International Company Details
11.12.2 Grifols International Business Overview
11.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) Introduction
11.12.4 Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.12.5 Grifols International Recent Development
11.13 Fresenius Kabi
11.13.1 Fresenius Kabi Company Details
11.13.2 Fresenius Kabi Business Overview
11.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Introduction
11.13.4 Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.13.5 Fresenius Kabi Recent Development
11.14 Sichuan Kelun Pharmaceutical
11.14.1 Sichuan Kelun Pharmaceutical Company Details
11.14.2 Sichuan Kelun Pharmaceutical Business Overview
11.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Introduction
11.14.4 Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.14.5 Sichuan Kelun Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Carbohydrates
1.2.3 Parenteral Lipid Emulsion
1.2.4 Single Dose Amino Acid Solution
1.2.5 Trace Elements
1.2.6 Vitamins and Minerals
1.3 Market by Application
1.3.1 Global Peripheral Parenteral Nutrition (PPN) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Home
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Parenteral Nutrition (PPN) Market Perspective (2020-2031)
2.2 Global Peripheral Parenteral Nutrition (PPN) Growth Trends by Region
2.2.1 Global Peripheral Parenteral Nutrition (PPN) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peripheral Parenteral Nutrition (PPN) Historic Market Size by Region (2020-2025)
2.2.3 Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Region (2026-2031)
2.3 Peripheral Parenteral Nutrition (PPN) Market Dynamics
2.3.1 Peripheral Parenteral Nutrition (PPN) Industry Trends
2.3.2 Peripheral Parenteral Nutrition (PPN) Market Drivers
2.3.3 Peripheral Parenteral Nutrition (PPN) Market Challenges
2.3.4 Peripheral Parenteral Nutrition (PPN) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Parenteral Nutrition (PPN) Players by Revenue
3.1.1 Global Top Peripheral Parenteral Nutrition (PPN) Players by Revenue (2020-2025)
3.1.2 Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Players (2020-2025)
3.2 Global Peripheral Parenteral Nutrition (PPN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peripheral Parenteral Nutrition (PPN) Revenue
3.4 Global Peripheral Parenteral Nutrition (PPN) Market Concentration Ratio
3.4.1 Global Peripheral Parenteral Nutrition (PPN) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Parenteral Nutrition (PPN) Revenue in 2024
3.5 Global Key Players of Peripheral Parenteral Nutrition (PPN) Head office and Area Served
3.6 Global Key Players of Peripheral Parenteral Nutrition (PPN), Product and Application
3.7 Global Key Players of Peripheral Parenteral Nutrition (PPN), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Parenteral Nutrition (PPN) Breakdown Data by Type
4.1 Global Peripheral Parenteral Nutrition (PPN) Historic Market Size by Type (2020-2025)
4.2 Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Type (2026-2031)
5 Peripheral Parenteral Nutrition (PPN) Breakdown Data by Application
5.1 Global Peripheral Parenteral Nutrition (PPN) Historic Market Size by Application (2020-2025)
5.2 Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peripheral Parenteral Nutrition (PPN) Market Size (2020-2031)
6.2 North America Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025)
6.4 North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peripheral Parenteral Nutrition (PPN) Market Size (2020-2031)
7.2 Europe Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025)
7.4 Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size (2020-2031)
8.2 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2020-2025)
8.4 Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peripheral Parenteral Nutrition (PPN) Market Size (2020-2031)
9.2 Latin America Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025)
9.4 Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size (2020-2031)
10.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025)
10.4 Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofarma
11.1.1 Eurofarma Company Details
11.1.2 Eurofarma Business Overview
11.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) Introduction
11.1.4 Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.1.5 Eurofarma Recent Development
11.2 Corporacion De Laboratorios Farmaceuticos
11.2.1 Corporacion De Laboratorios Farmaceuticos Company Details
11.2.2 Corporacion De Laboratorios Farmaceuticos Business Overview
11.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Introduction
11.2.4 Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.2.5 Corporacion De Laboratorios Farmaceuticos Recent Development
11.3 Baxter International Inc.
11.3.1 Baxter International Inc. Company Details
11.3.2 Baxter International Inc. Business Overview
11.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Introduction
11.3.4 Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.3.5 Baxter International Inc. Recent Development
11.4 Kelun Pharma
11.4.1 Kelun Pharma Company Details
11.4.2 Kelun Pharma Business Overview
11.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) Introduction
11.4.4 Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.4.5 Kelun Pharma Recent Development
11.5 B. Braun
11.5.1 B. Braun Company Details
11.5.2 B. Braun Business Overview
11.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) Introduction
11.5.4 B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.5.5 B. Braun Recent Development
11.6 Fresenius
11.6.1 Fresenius Company Details
11.6.2 Fresenius Business Overview
11.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) Introduction
11.6.4 Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.6.5 Fresenius Recent Development
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Details
11.7.2 Teva Pharmaceutical Industries Business Overview
11.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Introduction
11.7.4 Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.7.5 Teva Pharmaceutical Industries Recent Development
11.8 Pfizer (Hospira)
11.8.1 Pfizer (Hospira) Company Details
11.8.2 Pfizer (Hospira) Business Overview
11.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Introduction
11.8.4 Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.8.5 Pfizer (Hospira) Recent Development
11.9 Ostuka Pharmaceutical
11.9.1 Ostuka Pharmaceutical Company Details
11.9.2 Ostuka Pharmaceutical Business Overview
11.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Introduction
11.9.4 Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.9.5 Ostuka Pharmaceutical Recent Development
11.10 Laboratorios Biogalenic
11.10.1 Laboratorios Biogalenic Company Details
11.10.2 Laboratorios Biogalenic Business Overview
11.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Introduction
11.10.4 Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.10.5 Laboratorios Biogalenic Recent Development
11.11 Laboratorios Finlay
11.11.1 Laboratorios Finlay Company Details
11.11.2 Laboratorios Finlay Business Overview
11.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Introduction
11.11.4 Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.11.5 Laboratorios Finlay Recent Development
11.12 Grifols International
11.12.1 Grifols International Company Details
11.12.2 Grifols International Business Overview
11.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) Introduction
11.12.4 Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.12.5 Grifols International Recent Development
11.13 Fresenius Kabi
11.13.1 Fresenius Kabi Company Details
11.13.2 Fresenius Kabi Business Overview
11.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Introduction
11.13.4 Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.13.5 Fresenius Kabi Recent Development
11.14 Sichuan Kelun Pharmaceutical
11.14.1 Sichuan Kelun Pharmaceutical Company Details
11.14.2 Sichuan Kelun Pharmaceutical Business Overview
11.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Introduction
11.14.4 Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
11.14.5 Sichuan Kelun Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Carbohydrates
Table 3. Key Players of Parenteral Lipid Emulsion
Table 4. Key Players of Single Dose Amino Acid Solution
Table 5. Key Players of Trace Elements
Table 6. Key Players of Vitamins and Minerals
Table 7. Global Peripheral Parenteral Nutrition (PPN) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Peripheral Parenteral Nutrition (PPN) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Peripheral Parenteral Nutrition (PPN) Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region (2020-2025)
Table 11. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region (2026-2031)
Table 13. Peripheral Parenteral Nutrition (PPN) Market Trends
Table 14. Peripheral Parenteral Nutrition (PPN) Market Drivers
Table 15. Peripheral Parenteral Nutrition (PPN) Market Challenges
Table 16. Peripheral Parenteral Nutrition (PPN) Market Restraints
Table 17. Global Peripheral Parenteral Nutrition (PPN) Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Peripheral Parenteral Nutrition (PPN) Market Share by Players (2020-2025)
Table 19. Global Top Peripheral Parenteral Nutrition (PPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) as of 2024)
Table 20. Ranking of Global Top Peripheral Parenteral Nutrition (PPN) Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Peripheral Parenteral Nutrition (PPN) Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Peripheral Parenteral Nutrition (PPN), Headquarters and Area Served
Table 23. Global Key Players of Peripheral Parenteral Nutrition (PPN), Product and Application
Table 24. Global Key Players of Peripheral Parenteral Nutrition (PPN), Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Peripheral Parenteral Nutrition (PPN) Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Type (2020-2025)
Table 28. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Type (2026-2031)
Table 30. Global Peripheral Parenteral Nutrition (PPN) Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Application (2020-2025)
Table 32. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Application (2026-2031)
Table 34. North America Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031) & (US$ Million)
Table 49. Eurofarma Company Details
Table 50. Eurofarma Business Overview
Table 51. Eurofarma Peripheral Parenteral Nutrition (PPN) Product
Table 52. Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 53. Eurofarma Recent Development
Table 54. Corporacion De Laboratorios Farmaceuticos Company Details
Table 55. Corporacion De Laboratorios Farmaceuticos Business Overview
Table 56. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Product
Table 57. Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 58. Corporacion De Laboratorios Farmaceuticos Recent Development
Table 59. Baxter International Inc. Company Details
Table 60. Baxter International Inc. Business Overview
Table 61. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product
Table 62. Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 63. Baxter International Inc. Recent Development
Table 64. Kelun Pharma Company Details
Table 65. Kelun Pharma Business Overview
Table 66. Kelun Pharma Peripheral Parenteral Nutrition (PPN) Product
Table 67. Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 68. Kelun Pharma Recent Development
Table 69. B. Braun Company Details
Table 70. B. Braun Business Overview
Table 71. B. Braun Peripheral Parenteral Nutrition (PPN) Product
Table 72. B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 73. B. Braun Recent Development
Table 74. Fresenius Company Details
Table 75. Fresenius Business Overview
Table 76. Fresenius Peripheral Parenteral Nutrition (PPN) Product
Table 77. Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 78. Fresenius Recent Development
Table 79. Teva Pharmaceutical Industries Company Details
Table 80. Teva Pharmaceutical Industries Business Overview
Table 81. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Product
Table 82. Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 83. Teva Pharmaceutical Industries Recent Development
Table 84. Pfizer (Hospira) Company Details
Table 85. Pfizer (Hospira) Business Overview
Table 86. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Product
Table 87. Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 88. Pfizer (Hospira) Recent Development
Table 89. Ostuka Pharmaceutical Company Details
Table 90. Ostuka Pharmaceutical Business Overview
Table 91. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product
Table 92. Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 93. Ostuka Pharmaceutical Recent Development
Table 94. Laboratorios Biogalenic Company Details
Table 95. Laboratorios Biogalenic Business Overview
Table 96. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Product
Table 97. Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 98. Laboratorios Biogalenic Recent Development
Table 99. Laboratorios Finlay Company Details
Table 100. Laboratorios Finlay Business Overview
Table 101. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Product
Table 102. Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 103. Laboratorios Finlay Recent Development
Table 104. Grifols International Company Details
Table 105. Grifols International Business Overview
Table 106. Grifols International Peripheral Parenteral Nutrition (PPN) Product
Table 107. Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 108. Grifols International Recent Development
Table 109. Fresenius Kabi Company Details
Table 110. Fresenius Kabi Business Overview
Table 111. Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Product
Table 112. Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 113. Fresenius Kabi Recent Development
Table 114. Sichuan Kelun Pharmaceutical Company Details
Table 115. Sichuan Kelun Pharmaceutical Business Overview
Table 116. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product
Table 117. Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 118. Sichuan Kelun Pharmaceutical Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report
List of Figures
Figure 1. Peripheral Parenteral Nutrition (PPN) Picture
Figure 2. Global Peripheral Parenteral Nutrition (PPN) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peripheral Parenteral Nutrition (PPN) Market Share by Type: 2024 VS 2031
Figure 4. Carbohydrates Features
Figure 5. Parenteral Lipid Emulsion Features
Figure 6. Single Dose Amino Acid Solution Features
Figure 7. Trace Elements Features
Figure 8. Vitamins and Minerals Features
Figure 9. Global Peripheral Parenteral Nutrition (PPN) Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Peripheral Parenteral Nutrition (PPN) Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Home Case Studies
Figure 13. Peripheral Parenteral Nutrition (PPN) Report Years Considered
Figure 14. Global Peripheral Parenteral Nutrition (PPN) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Peripheral Parenteral Nutrition (PPN) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region: 2024 VS 2031
Figure 17. Global Peripheral Parenteral Nutrition (PPN) Market Share by Players in 2024
Figure 18. Global Top Peripheral Parenteral Nutrition (PPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Peripheral Parenteral Nutrition (PPN) Revenue in 2024
Figure 20. North America Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Peripheral Parenteral Nutrition (PPN) Market Share by Country (2020-2031)
Figure 22. United States Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Peripheral Parenteral Nutrition (PPN) Market Share by Country (2020-2031)
Figure 26. Germany Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Share by Region (2020-2031)
Figure 34. China Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Peripheral Parenteral Nutrition (PPN) Market Share by Country (2020-2031)
Figure 42. Mexico Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Share by Country (2020-2031)
Figure 46. Turkey Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Eurofarma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 50. Corporacion De Laboratorios Farmaceuticos Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 51. Baxter International Inc. Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 52. Kelun Pharma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 53. B. Braun Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 54. Fresenius Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 55. Teva Pharmaceutical Industries Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 56. Pfizer (Hospira) Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 57. Ostuka Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 58. Laboratorios Biogalenic Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 59. Laboratorios Finlay Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 60. Grifols International Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 61. Fresenius Kabi Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 62. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Carbohydrates
Table 3. Key Players of Parenteral Lipid Emulsion
Table 4. Key Players of Single Dose Amino Acid Solution
Table 5. Key Players of Trace Elements
Table 6. Key Players of Vitamins and Minerals
Table 7. Global Peripheral Parenteral Nutrition (PPN) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Peripheral Parenteral Nutrition (PPN) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Peripheral Parenteral Nutrition (PPN) Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region (2020-2025)
Table 11. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region (2026-2031)
Table 13. Peripheral Parenteral Nutrition (PPN) Market Trends
Table 14. Peripheral Parenteral Nutrition (PPN) Market Drivers
Table 15. Peripheral Parenteral Nutrition (PPN) Market Challenges
Table 16. Peripheral Parenteral Nutrition (PPN) Market Restraints
Table 17. Global Peripheral Parenteral Nutrition (PPN) Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Peripheral Parenteral Nutrition (PPN) Market Share by Players (2020-2025)
Table 19. Global Top Peripheral Parenteral Nutrition (PPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) as of 2024)
Table 20. Ranking of Global Top Peripheral Parenteral Nutrition (PPN) Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Peripheral Parenteral Nutrition (PPN) Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Peripheral Parenteral Nutrition (PPN), Headquarters and Area Served
Table 23. Global Key Players of Peripheral Parenteral Nutrition (PPN), Product and Application
Table 24. Global Key Players of Peripheral Parenteral Nutrition (PPN), Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Peripheral Parenteral Nutrition (PPN) Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Type (2020-2025)
Table 28. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Type (2026-2031)
Table 30. Global Peripheral Parenteral Nutrition (PPN) Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Application (2020-2025)
Table 32. Global Peripheral Parenteral Nutrition (PPN) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Peripheral Parenteral Nutrition (PPN) Revenue Market Share by Application (2026-2031)
Table 34. North America Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size by Country (2026-2031) & (US$ Million)
Table 49. Eurofarma Company Details
Table 50. Eurofarma Business Overview
Table 51. Eurofarma Peripheral Parenteral Nutrition (PPN) Product
Table 52. Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 53. Eurofarma Recent Development
Table 54. Corporacion De Laboratorios Farmaceuticos Company Details
Table 55. Corporacion De Laboratorios Farmaceuticos Business Overview
Table 56. Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) Product
Table 57. Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 58. Corporacion De Laboratorios Farmaceuticos Recent Development
Table 59. Baxter International Inc. Company Details
Table 60. Baxter International Inc. Business Overview
Table 61. Baxter International Inc. Peripheral Parenteral Nutrition (PPN) Product
Table 62. Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 63. Baxter International Inc. Recent Development
Table 64. Kelun Pharma Company Details
Table 65. Kelun Pharma Business Overview
Table 66. Kelun Pharma Peripheral Parenteral Nutrition (PPN) Product
Table 67. Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 68. Kelun Pharma Recent Development
Table 69. B. Braun Company Details
Table 70. B. Braun Business Overview
Table 71. B. Braun Peripheral Parenteral Nutrition (PPN) Product
Table 72. B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 73. B. Braun Recent Development
Table 74. Fresenius Company Details
Table 75. Fresenius Business Overview
Table 76. Fresenius Peripheral Parenteral Nutrition (PPN) Product
Table 77. Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 78. Fresenius Recent Development
Table 79. Teva Pharmaceutical Industries Company Details
Table 80. Teva Pharmaceutical Industries Business Overview
Table 81. Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) Product
Table 82. Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 83. Teva Pharmaceutical Industries Recent Development
Table 84. Pfizer (Hospira) Company Details
Table 85. Pfizer (Hospira) Business Overview
Table 86. Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) Product
Table 87. Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 88. Pfizer (Hospira) Recent Development
Table 89. Ostuka Pharmaceutical Company Details
Table 90. Ostuka Pharmaceutical Business Overview
Table 91. Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product
Table 92. Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 93. Ostuka Pharmaceutical Recent Development
Table 94. Laboratorios Biogalenic Company Details
Table 95. Laboratorios Biogalenic Business Overview
Table 96. Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) Product
Table 97. Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 98. Laboratorios Biogalenic Recent Development
Table 99. Laboratorios Finlay Company Details
Table 100. Laboratorios Finlay Business Overview
Table 101. Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) Product
Table 102. Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 103. Laboratorios Finlay Recent Development
Table 104. Grifols International Company Details
Table 105. Grifols International Business Overview
Table 106. Grifols International Peripheral Parenteral Nutrition (PPN) Product
Table 107. Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 108. Grifols International Recent Development
Table 109. Fresenius Kabi Company Details
Table 110. Fresenius Kabi Business Overview
Table 111. Fresenius Kabi Peripheral Parenteral Nutrition (PPN) Product
Table 112. Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 113. Fresenius Kabi Recent Development
Table 114. Sichuan Kelun Pharmaceutical Company Details
Table 115. Sichuan Kelun Pharmaceutical Business Overview
Table 116. Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) Product
Table 117. Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) Business (2020-2025) & (US$ Million)
Table 118. Sichuan Kelun Pharmaceutical Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report
List of Figures
Figure 1. Peripheral Parenteral Nutrition (PPN) Picture
Figure 2. Global Peripheral Parenteral Nutrition (PPN) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peripheral Parenteral Nutrition (PPN) Market Share by Type: 2024 VS 2031
Figure 4. Carbohydrates Features
Figure 5. Parenteral Lipid Emulsion Features
Figure 6. Single Dose Amino Acid Solution Features
Figure 7. Trace Elements Features
Figure 8. Vitamins and Minerals Features
Figure 9. Global Peripheral Parenteral Nutrition (PPN) Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Peripheral Parenteral Nutrition (PPN) Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Home Case Studies
Figure 13. Peripheral Parenteral Nutrition (PPN) Report Years Considered
Figure 14. Global Peripheral Parenteral Nutrition (PPN) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Peripheral Parenteral Nutrition (PPN) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Peripheral Parenteral Nutrition (PPN) Market Share by Region: 2024 VS 2031
Figure 17. Global Peripheral Parenteral Nutrition (PPN) Market Share by Players in 2024
Figure 18. Global Top Peripheral Parenteral Nutrition (PPN) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Parenteral Nutrition (PPN) as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Peripheral Parenteral Nutrition (PPN) Revenue in 2024
Figure 20. North America Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Peripheral Parenteral Nutrition (PPN) Market Share by Country (2020-2031)
Figure 22. United States Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Peripheral Parenteral Nutrition (PPN) Market Share by Country (2020-2031)
Figure 26. Germany Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Peripheral Parenteral Nutrition (PPN) Market Share by Region (2020-2031)
Figure 34. China Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Peripheral Parenteral Nutrition (PPN) Market Share by Country (2020-2031)
Figure 42. Mexico Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Peripheral Parenteral Nutrition (PPN) Market Share by Country (2020-2031)
Figure 46. Turkey Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Peripheral Parenteral Nutrition (PPN) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Eurofarma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 50. Corporacion De Laboratorios Farmaceuticos Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 51. Baxter International Inc. Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 52. Kelun Pharma Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 53. B. Braun Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 54. Fresenius Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 55. Teva Pharmaceutical Industries Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 56. Pfizer (Hospira) Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 57. Ostuka Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 58. Laboratorios Biogalenic Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 59. Laboratorios Finlay Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 60. Grifols International Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 61. Fresenius Kabi Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 62. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Peripheral Parenteral Nutrition (PPN) Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232